Skip to main content

Table 3 Reasons indicated by Continuers and Converts for completing the FIT in 2012

From: Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study

 

Continuers

Converts

Continuers

Converts

 

All

All

Men

Women

Men

Women

(N = 600)

(N = 308)

(N = 315)

(N = 285)

(N = 138)

(N = 170)

Wtd. %

Wtd. %

Wtd. %

Wtd. %

Wtd. %

Wtd. %

People who really wanted me to do it

      

 My doctor

44.2

54.0

52.4

37.4*

58.5

50.5

 My spouse/partner

      

  All

19.4

23.2

33.4

7.8*

41.8

8.5 *

  Those in a committed relationship

24.6

34.1

38.9

10.8*

53.2

13.9*

 My children/grandchildren

3.7

6.9

5.2

2.4

2.9

10.1*,**

I know someone with a history of CRC or colon polyps

27.3

20.1

17.8

35.2*

14.7

24.5

Peace of mind/prevention

      

 I wanted to make sure I was OK

72.6

53.7**

68.9

75.7

51.2 **

55.7**

 FIT test can help me protect my health

76.4

46.1**

70.5

81.3*

38.5 **

52.1**

 When colorectal polyps are found and removed, CRC can be prevented

41.3

22.7**

36.0

45.8

24.9

21.1**

 FIT is more convenient than other CRC screening methods

66.2

41.0**

59.9

71.4*

35.2**

45.5**

Felt guilty after receiving so many kits

      

 All

4.6

47.2**

1.8

7.0

37.9**

54.5**

 Those who recalled getting >1 kita

12.3

65.3**

0.7

12.7*

68.9**

63.4**

  1. Wtd weighted, FIT fecal immunochemical test, CRC colorectal cancer
  2. *Significant (P < .05) difference between sexes within Continuer or Convert group after adjusting for age group and race/ethnicity
  3. **Significant (P < .05) difference between Convert and Continuer group within sex group after adjusting for age group and race/ethnicity
  4. a43 (13.6 %) men and 59 (20.7 %) women in the Continuer group reported getting multiple FIT kits whereas 69 (50.0 %) men and 114 (67.0 %) women in the Convert group reported getting multiple kits